Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

By Sin J.-I.   Sung J.-H.   Suh Y.-S.   Lee A.-H.   Chung J.-H.   Sung Y.-C.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1827-1833

Elsevier

Access to resources Recommend Favorite

Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination

By Sun X.   Hodge L.M.   Jones H.P.   Tabor L.   Simecka J.W.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1466-1474

Elsevier

Access to resources Recommend Favorite

Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor

By Ishii K.J.   Weiss W.R.   Klinman D.M.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 703-710

Elsevier

Access to resources Recommend Favorite

Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

By Argiro L.   Henri S.   Dessein H.   Dessein A.J.   Bourgois A.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 13-18

Elsevier

Access to resources Recommend Favorite

Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine

By Tarr P.E.   Lin R.   Mueller E.A.   Kovarik J.M.   Guillaumes M.   Jones T.C.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1199-1204

Elsevier

Access to resources Recommend Favorite